Detalhe da pesquisa
1.
Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
J Nanobiotechnology
; 14(1): 60, 2016 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27455834
2.
Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma.
Nanomedicine
; 11(1): 247-57, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24983891
3.
The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.
Small
; 10(6): 1116-24, 2014 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24659273
4.
The In Vivo Radiosensitizing Effect of Gold Nanoparticles Based MRI Contrast Agents.
Small
; 2014 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24677791
5.
Gadolinium-based nanoparticles to improve the hadrontherapy performances.
Nanomedicine
; 10(8): 1601-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24846523
6.
Ultrasmall rigid particles as multimodal probes for medical applications.
Angew Chem Int Ed Engl
; 50(51): 12299-303, 2011 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22057640
7.
Improving proton therapy by metal-containing nanoparticles: nanoscale insights.
Int J Nanomedicine
; 11: 1549-56, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143877
8.
Biodistribution of ultra small gadolinium-based nanoparticles as theranostic agent: application to brain tumors.
J Biomater Appl
; 28(3): 385-94, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22832216
9.
Paramagnetic nanoparticles to track and quantify in vivo immune human therapeutic cells.
Nanoscale
; 5(23): 11409-15, 2013 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23838997
10.
Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles.
Biomaterials
; 34(1): 181-95, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23046756
11.
Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles.
ACS Nano
; 5(12): 9566-74, 2011 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22040385
12.
Single-scan quantitative T2* methods with susceptibility artifact reduction.
NMR Biomed
; 19(5): 527-34, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16598696